Proleukin® (aldesleukin) is prescribed to treat cancer that has started in the skin or kidney and has spread to other areas of the body (metastasized). It is given through an intravenous (IV) infusion by a healthcare provider. It is given every eight hours for five days, followed by a nine-day break, and then another five days of treatment.
Proleukin is only available as a brand-name product, as certain laws and regulations prevent it from being manufactured in generic form. This is because Proleukin is a type of "biologic" medication, meaning it is made using live cells rather than created chemically. However, these laws are beginning to change, and there may be generic versions of Proleukin available at a future date.
Proleukin is made by Prometheus Laboratories, Inc. It comes in one strength: Proleukin 22 million international units per vial (1.3 mg per vial).
(For more information on this brand-name chemotherapy drug, click Proleukin. This article describes dosing guidelines, potential side effects, and general safety precautions.)